The researchers who are changing the story of ovarian cancer
We meet Cambridge researchers leading a pioneering programme to help more women survive ovarian cancer.
Only 43% of women in England survive five years beyond their ovarian cancer diagnosis. Professors James Brenton and Evis Sala aim to change this.
Their research at the Mark Foundation Institute for Integrated Cancer Medicine at the Cancer Research UK (CRUK) Cambridge Centre is bringing together complex data (clinical features, imaging, genomic data, molecular tests, tumour pathology, treatment outcomes and so on) with machine learning techniques to help clinicians make better decisions for patients, not just in Cambridge but across the UK and the world.
#ItTakesImagination
To find out more, read https://www.cam.ac.uk/stories/ovarian-cancer
The Mark Foundation Institute for Integrated Cancer Medicine: https://www.integratedcancermedicine.org/
CRUK Cancer Research UK (CRUK) Cambridge Centre: https://crukcambridgecentre.org.uk/
This research was supported by Cambridge University Hospitals NHS Foundation Trust, the CRUK Cambridge Centre, the CRUK Cambridge Institute, The Mark Foundation for Cancer Research US Ltd, Ovarian Cancer Action and the NIHR Cambridge Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NIHR, the Department of Health and Social Care or other funders.
No comments found